874 related articles for article (PubMed ID: 23824486)
1. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice.
Williams AH; Valdez G; Moresi V; Qi X; McAnally J; Elliott JL; Bassel-Duby R; Sanes JR; Olson EN
Science; 2009 Dec; 326(5959):1549-54. PubMed ID: 20007902
[TBL] [Abstract][Full Text] [Related]
3. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
Yoo YE; Ko CP
Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
[TBL] [Abstract][Full Text] [Related]
4. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
5. Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice.
Buonvicino D; Felici R; Ranieri G; Caramelli R; Lapucci A; Cavone L; Muzzi M; Di Pietro L; Bernardini C; Zwergel C; Valente S; Mai A; Chiarugi A
Neuroscience; 2018 May; 379():228-238. PubMed ID: 29588251
[TBL] [Abstract][Full Text] [Related]
6. Monitoring disease progression using high-density motor unit number estimation in amyotrophic lateral sclerosis.
van Dijk JP; Schelhaas HJ; Van Schaik IN; Janssen HM; Stegeman DF; Zwarts MJ
Muscle Nerve; 2010 Aug; 42(2):239-44. PubMed ID: 20544934
[TBL] [Abstract][Full Text] [Related]
7. Medicine. A reinnervating microRNA.
Brown RH
Science; 2009 Dec; 326(5959):1494-5. PubMed ID: 20007892
[No Abstract] [Full Text] [Related]
8. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.
Ringer C; Weihe E; Schütz B
Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254
[TBL] [Abstract][Full Text] [Related]
9. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.
Schaefer AM; Sanes JR; Lichtman JW
J Comp Neurol; 2005 Sep; 490(3):209-19. PubMed ID: 16082680
[TBL] [Abstract][Full Text] [Related]
10. The role of muscle microRNAs in repairing the neuromuscular junction.
Valdez G; Heyer MP; Feng G; Sanes JR
PLoS One; 2014; 9(3):e93140. PubMed ID: 24664281
[TBL] [Abstract][Full Text] [Related]
11. Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
Marcuzzo S; Zucca I; Mastropietro A; de Rosbo NK; Cavalcante P; Tartari S; Bonanno S; Preite L; Mantegazza R; Bernasconi P
Exp Neurol; 2011 Sep; 231(1):30-7. PubMed ID: 21620832
[TBL] [Abstract][Full Text] [Related]
12. Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model.
Gonzalez de Aguilar JL; Niederhauser-Wiederkehr C; Halter B; De Tapia M; Di Scala F; Demougin P; Dupuis L; Primig M; Meininger V; Loeffler JP
Physiol Genomics; 2008 Jan; 32(2):207-18. PubMed ID: 18000159
[TBL] [Abstract][Full Text] [Related]
13. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
14. Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis.
Janssen C; Schmalbach S; Boeselt S; Sarlette A; Dengler R; Petri S
J Neuropathol Exp Neurol; 2010 Jun; 69(6):573-81. PubMed ID: 20467334
[TBL] [Abstract][Full Text] [Related]
15. Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice.
Ryu H; Smith K; Camelo SI; Carreras I; Lee J; Iglesias AH; Dangond F; Cormier KA; Cudkowicz ME; Brown RH; Ferrante RJ
J Neurochem; 2005 Jun; 93(5):1087-98. PubMed ID: 15934930
[TBL] [Abstract][Full Text] [Related]
16. Neuropathologic and biochemical changes during disease progression in liver X receptor beta-/- mice, a model of adult neuron disease.
Bigini P; Steffensen KR; Ferrario A; Diomede L; Ferrara G; Barbera S; Salzano S; Fumagalli E; Ghezzi P; Mennini T; Gustafsson JA
J Neuropathol Exp Neurol; 2010 Jun; 69(6):593-605. PubMed ID: 20467332
[TBL] [Abstract][Full Text] [Related]
17. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.
Martinez JA; Francis GJ; Liu WQ; Pradzinsky N; Fine J; Wilson M; Hanson LR; Frey WH; Zochodne D; Gordon T; Toth C
Neuroscience; 2008 Dec; 157(4):908-25. PubMed ID: 18951954
[TBL] [Abstract][Full Text] [Related]
18. Motor unit number estimation predicts disease onset and survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Shefner JM; Cudkowicz M; Brown RH
Muscle Nerve; 2006 Nov; 34(5):603-7. PubMed ID: 16892429
[TBL] [Abstract][Full Text] [Related]
19. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis.
Liu KX; Edwards B; Lee S; Finelli MJ; Davies B; Davies KE; Oliver PL
Brain; 2015 May; 138(Pt 5):1167-81. PubMed ID: 25753484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
